ArticleInvestigational new drugs2022

Real-world evaluation of second line chemotherapy for patients with advanced non-small cell lung cancer harboring preexisting interstitial lung disease.

Satoshi Igawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.